Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Use good lighting, consistent positioning, and proper camera settings for effective hair disorder photos.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.